1. Home
  2. KALA vs NWGL Comparison

KALA vs NWGL Comparison

Compare KALA & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • NWGL
  • Stock Information
  • Founded
  • KALA 2009
  • NWGL 2008
  • Country
  • KALA United States
  • NWGL Macau
  • Employees
  • KALA N/A
  • NWGL N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • KALA Health Care
  • NWGL
  • Exchange
  • KALA Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • KALA 26.2M
  • NWGL 26.2M
  • IPO Year
  • KALA 2017
  • NWGL 2023
  • Fundamental
  • Price
  • KALA $5.10
  • NWGL $1.08
  • Analyst Decision
  • KALA Strong Buy
  • NWGL
  • Analyst Count
  • KALA 3
  • NWGL 0
  • Target Price
  • KALA $14.00
  • NWGL N/A
  • AVG Volume (30 Days)
  • KALA 71.3K
  • NWGL 866.8K
  • Earning Date
  • KALA 08-05-2025
  • NWGL 07-15-2025
  • Dividend Yield
  • KALA N/A
  • NWGL N/A
  • EPS Growth
  • KALA N/A
  • NWGL N/A
  • EPS
  • KALA N/A
  • NWGL N/A
  • Revenue
  • KALA N/A
  • NWGL $21,539,347.00
  • Revenue This Year
  • KALA N/A
  • NWGL N/A
  • Revenue Next Year
  • KALA N/A
  • NWGL N/A
  • P/E Ratio
  • KALA N/A
  • NWGL N/A
  • Revenue Growth
  • KALA N/A
  • NWGL N/A
  • 52 Week Low
  • KALA $2.92
  • NWGL $0.91
  • 52 Week High
  • KALA $11.20
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • KALA 62.32
  • NWGL 44.94
  • Support Level
  • KALA $4.36
  • NWGL $0.91
  • Resistance Level
  • KALA $5.90
  • NWGL $6.61
  • Average True Range (ATR)
  • KALA 0.50
  • NWGL 0.59
  • MACD
  • KALA 0.07
  • NWGL -0.13
  • Stochastic Oscillator
  • KALA 61.50
  • NWGL 2.11

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: